About BeaconCure
BeaconCure is a Healthcare company based in Tel Aviv (Israel) founded in 2016. It operates as a data analytics and validation software for regulatory submission in the healthcare sector. It operates in the Healthcare and Technology sectors. BeaconCure has raised $40.92 million across 4 funding rounds from investors including NewVale Capital. BeaconCure offers products and services including Verify. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Medical AI Data Validation. Its competitors include Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access and 2 more; 4 of its 7 listed competitors have raised funding.
Company details
BeaconCure was founded in 2016 in Tel Aviv, Israel, within the healthcare sector. Software for data analytics and validation is developed to support regulatory submissions for drug and vaccine development. Artificial intelligence is utilized to extract and analyze data from tables and text, while inconsistencies are tracked to ensure submission accuracy. Operations focus on identifying critical challenges in regulatory approvals.
- Headquarters Tel Aviv, Israel
- SectorsHealthcareTechnology
- Website beaconcure.com
- Social LinkedIn X Facebook
- Total Equity Funding$40.92M (USD)
in 4 rounds
- Latest Funding Round$14.99M (USD), Series C
Jan 2025
- Investors
Products & Services of BeaconCure
BeaconCure offers a comprehensive portfolio of products and services, including Verify.
Automates validation of clinical trial outputs using ML for accuracy.
Funding Insights of BeaconCure
BeaconCure has successfully raised a total of $40.92M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $14.99 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $40.92M
- Total Rounds 4
- Last Round Series C — $14.99M
- First Round $2.04M
(Nov 2021)
- Investors Count 1
All 4 funding rounds of BeaconCure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $14.99M | Series C | – | – | – |
| Jun 2023 | $14M | Series B | – | NewVale Capital | – |
| Mar 2023 | $9.89M | Series A | – | – | – |
| Nov 2021 | $2.04M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in BeaconCure
BeaconCure has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NewVale Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
NewVale Capital is focused on life sciences investment. | – | newvalecapital.com | - |
Investor details for BeaconCure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BeaconCure
13 people are tracked at BeaconCure (5 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Ilan Carmeli | COO & Co-Founder | Leadership |
Adam Heunis | Chief Technology Officer | Leadership |
Sharon Atzmon | Director Of Design And UX | Leadership |
Chuck Gelb | Vice President Of Global Sales | Leadership |
Michael Tober | Vice President Of Finance And Operations | Leadership |
Liron Dangoor | Data Analyst | Team |
Sarah Zakrzewski | Sr. Manager, Operations | Team |
★Mor Barki★ | Talent Acquisition Manager at Beaconcure ★ | Team |
Naama Levi Feldman | Data Operations Team Lead | Team |
Yoash Izhack | Devops Manager | Team |
Vladimir Gurevich | Machine Learning Engineer | Team |
Hadas Stein | Operations & Walfare Manager | Team |
Gilad Wainreb | Algorithm's Team Leader | Team |
Complete people profiles for BeaconCure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BeaconCure
3 dated milestones of BeaconCure across 9 years, from founding to its latest funding, stage changes and deals.
- Founded BeaconCure is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series C, of $15.0M.
Competitors of BeaconCure
BeaconCure has 7 listed competitors in our database, 4 of them funded. They include Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| definitivehc.com | 2008 | Natick, United States | $4.31M | 575 | Offers market intelligence and data analytics for healthcare providers and physicians | |
| eso.com | 2004 | Austin, United States | $50.4M | – | EHR platform for emergency services is provided. | |
| molecularconnections.com | 2002 | Bengaluru, India | – | 1,404 | Databases and analytics for drug discovery are provided. | |
| collaborativedrug.com | 2004 | Burlingame, United States | – | 31 | Biological and chemical data are managed securely in a database. | |
| borderlessaccess.com | 2008 | Bengaluru, India | $253,247 | 356 | Analytics-driven sampling suite for healthcare market research is offered. | |
| pharmetrics.com | 1998 | Watertown, United States | $26M | – | Patient-level healthcare data solutions are provided to pharmaceutical sectors. | |
| biocentury.com | 1992 | Redwood, United States | – | 171 | Information, analysis, and data for biotech and pharma are provided. |
Detailed competitors of BeaconCure
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BeaconCure
The website of BeaconCure (beaconcure.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 7.9% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as BeaconCure (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Beaconcure
Complete news archive for BeaconCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BeaconCure
BeaconCure was founded in 2016 and raised its 1st funding round 5 years after it was founded.
BeaconCure is headquartered in Tel Aviv, Israel.
BeaconCure is a funded company, having raised a total of $40.92M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.04M, raised on Nov 2021.
BeaconCure was founded in 2016 in Tel Aviv, Israel, within the healthcare sector. Software for data analytics and validation is developed to support regulatory submissions for drug and vaccine development. Artificial intelligence is utilized to extract and analyze data from tables and text, while inconsistencies are tracked to ensure submission accuracy. Operations focus on identifying critical challenges in regulatory approvals.
BeaconCure's top competitors include Definitive Healthcare, ESO and BioCentury.
BeaconCure offers Verify.
BeaconCure has 1 investor. Key investors include NewVale Capital.